- Trials with a EudraCT protocol (8)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (8)
8 result(s) found for: Chlorpromazine.
Displaying page 1 of 1.
| EudraCT Number: 2016-003131-38 | Sponsor Protocol Number: DOPA2016 | Start Date*: 2017-06-23 |
| Sponsor Name:TARGID, KU Leuven | ||
| Full Title: The effect of chlorpromazine (Largactil), a dopamine type 2-(D2-) receptor antagonist, on esophageal sensitivity in healthy volunteers: a randomized, double-blind, placebo-controlled study | ||
| Medical condition: Increased esophageal sensitivity in refractory gastro-esophageal reflux disease | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2007-007669-20 | Sponsor Protocol Number: 37822681SCH2003 | Start Date*: 2008-08-18 |
| Sponsor Name:Janssen-Cilag International NV, Turnhoutseweg 30, 2340 Beerse, Belgium | ||
| Full Title: A Double-Blind, Multiple Dose Titration Study to Investigate the Safety, Tolerability and Pharmacokinetics of Once Daily and Twice Daily Doses of JNJ-37822681 in Male and Female Patients With Stabl... | ||
| Medical condition: Schizophrenia | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: DE (Completed) SE (Prematurely Ended) BE (Completed) SK (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2021-001333-38 | Sponsor Protocol Number: CAVES | Start Date*: 2021-10-05 |
| Sponsor Name:Fundación Pública Andaluza para la Gestión de la Investigación en Salud de Sevilla (FISEVI) | ||
| Full Title: Cognitive effects of adjuntive Vortioxetine in early Schizophrenia | ||
| Medical condition: Early schizophrenia | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2017-001651-31 | Sponsor Protocol Number: 1.0 | Start Date*: 2017-11-30 |
| Sponsor Name:Newcastle upon Tyne Hospitals NHS Foundation Trust | ||
| Full Title: EMPOWER: EMesis in Pregnancy - Ondansetron With mEtoclopRamide. | ||
| Medical condition: Nausea and Vomiting in pregnancy Hyperemesis gravidarum | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2005-006048-42 | Sponsor Protocol Number: P04628 | Start Date*: 2006-09-05 | |||||||||||
| Sponsor Name:Schering-Plough Research Institute | |||||||||||||
| Full Title: A Phase 2a, Multiple-Dose, Placebo Controlled, Randomized, Two Way Crossover Study to Assess the Efficacy of SCH 420814 in Reducing Anti-Psychotic-Induced Extra-Pyramidal Symptoms Among Subjects Wi... | |||||||||||||
| Medical condition: Patients with schizophrenia and schizoaffective disorders experiencing anti-psychotic-induced extra-pyramidal symptoms. | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2017-001170-42 | Sponsor Protocol Number: SNR05 | Start Date*: 2019-07-12 |
| Sponsor Name:SyneuRx International (Taiwan) Corp | ||
| Full Title: An adaptive Phase II/III, Double-Blind, Randomized, Placebo-controlled, Two-Part, Dose-Finding, Multi-center Study of the Safety and Efficacy of NaBen® (sodium benzoate), a D-Amino Acid Oxidase In... | ||
| Medical condition: Treatment for Refractory Schizophrenia in Adults | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: DE (Ongoing) GB (GB - no longer in EU/EEA) PL (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2018-001581-42 | Sponsor Protocol Number: 17972A | Start Date*: 2018-11-19 | |||||||||||
| Sponsor Name:H. Lunbeck A/S | |||||||||||||
| Full Title: Interventional, randomized, double-blind, parallel-group, placebo-controlled, fixed-flexible-dose study of Lu AF11167 for the treatment of persistent prominent negative symptoms in patients with sc... | |||||||||||||
| Medical condition: schizophrenia with persistent prominent negative symptoms | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: EE (Prematurely Ended) LV (Prematurely Ended) HU (Completed) BG (Prematurely Ended) PL (Completed) CZ (Prematurely Ended) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2019-003369-16 | Sponsor Protocol Number: GWAP19030 | Start Date*: 2020-06-02 |
| Sponsor Name:GW Research Ltd. | ||
| Full Title: A Randomized, Double-blind, Parallel-group Trial to Investigate the Safety and Efficacy of GWP42003-P Versus Placebo as Adjunctive Therapy in Participants with Schizophrenia Experiencing Inadequate... | ||
| Medical condition: Schizophrenia is neurodevelopmental syndrome, results from gradual alterations in brain connectivity. Can persist for years before psychosis emerges. Individuals have a 2 to 3 fold increased risk o... | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: ES (Prematurely Ended) PL (Prematurely Ended) | ||
| Trial results: View results | ||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
